Main Navigation

• The Children's Inn
• National Cancer Institute, Childhood Cancers
• NIH Clinical Center
• Camp Fantastic

Pediatric Oncology Branch Home > Scientific Programs > Behavorial Science Core > Neurobehavioral Program > Recent Publications

Headline Title

Neurobehavioral Program

Recent Publications

Experiences of families with a child, adolescent, or young adult with neurofibromatosis type 1 and plexiform neurofibroma evaluated for clinical trials participation at the National Cancer Institute.
Martin S, Gillespie A, Wolters PL, Widemann BC.
Contemp Clin Trials. 2010 Oct 14. [Epub ahead of print]

A comparison of adherence assessment methods utilized in the United States: perspectives of researchers, HIV-infected children, and their caregivers.
Martin S, Elliott-DeSorbo DK, Calabrese S, Wolters PL, Roby G, Brennan T, Wood LV.
AIDS Patient Care STDS. 2009 Aug;23(8):593-601.

Neurodevelopment of children under 3 years of age with Smith-Magenis syndrome.
Wolters PL, Gropman AL, Martin SC, Smith MR, Hildenbrand HL, Brewer CC, Smith AC.
Pediatr Neurol. 2009 Oct;41(4):250-8.

Stressful life events and their relationship to psychological and medical functioning in children and adolescents with HIV infection.
Elliott-DeSorbo DK, Martin S, Wolters PL.
J Acquir Immune Defic Syndr. 2009 Nov 1;52(3):364-70.

Neuropsychological testing and biomarkers in the management of brain metastases.
Baschnagel A, Wolters PL, Camphausen K.
Radiat Oncol. 2008 Sep 17;3:26

Detection and characterization of neurotoxicity in cancer patients using proton MR spectroscopy.
Steffen-Smith EA, Wolters PL, Albert PS, Baker EH, Shimoda KC, Barnett AS, Warren KE.
Childs Nerv Syst. 2008 Jul;24(7):807-13. Epub 2008 Feb 22.

Phase I trial of pirfenidone in children with neurofibromatosis type 1 and plexiform neurofibromas.
Babovic-Vuksanovic, D., Widemann, B. C., Dombi, E., Gillespie, A., Wolters,P. L., Toledo-Tamula, M. A., O’Neill, B. P., Fox, E., Steinberg, S., MacDonald, T., Beck, H., & Packer, R. (2007).  Pediatric Neurology, 36 (5), 293 - 300.

Immunologic, virologic, and neuropsychologic responses in HIV-infected children receiving their first HAART regimen.
Hazra, R., Jankelevich, S., Mackall, C., Avila, N., Wolters, P., Civitello, L., Jacobsen, F., Steinberg, S., & Yarchoan, R. (2007). Viral Immunology, 20 (1), 131 - 141.

Very high-dose methotrexate (33.6 g/m2) as CNS preventive therapy for childhood acute lymphoblastic leukemia: Results of National Cancer Institute/Children’s Cancer Group trials CCG-191P, CCG-134P, and CCG-144P.
Nathan, P. C., Whitcomb, T., Wolters, P. L., Steinberg, S. M., Balis, F. M. Brouwers, P., Hunsberger, S., Feusner, J., Sather, H., Miser, J., Odom, L. F., Poplack, D., Reaman, G., Bleyer, W. A. (2006). Leukemia & Lymphoma, 47 (12), 2488 - 2504.

Cognitive functioning in school-aged children with vertically acquired HIV infection being treated with highly active antiretroviral therapy (HAART).
Martin SC, Wolters PL, Toledo-Tamula MA, Zeichner SL, Hazra R, Civitello L.
Dev Neuropsychol. 2006;30(2):633-57.

Coping styles among families of children with HIV infection.
Martin SC, Wolters PL, Klaas PA, Perez L, Wood LV.
AIDS Care. 2004 Apr;16(3):283-92.

return to the top